Caution regarding the specificities of pan-cancer microbial structure
- PMID: 37555750
- PMCID: PMC10483429
- DOI: 10.1099/mgen.0.001088
Caution regarding the specificities of pan-cancer microbial structure
Abstract
Results published in an article by Poore et al. (Nature. 2020;579:567-574) suggested that machine learning models can almost perfectly distinguish between tumour types based on their microbial composition using machine learning models. Whilst we believe that there is the potential for microbial composition to be used in this manner, we have concerns with the paper that make us question the certainty of the conclusions drawn. We believe there are issues in the areas of the contribution of contamination, handling of batch effects, false positive classifications and limitations in the machine learning approaches used. This makes it difficult to identify whether the authors have identified true biological signal and how robust these models would be in use as clinical biomarkers. We commend Poore et al. on their approach to open data and reproducibility that has enabled this analysis. We hope that this discourse assists the future development of machine learning models and hypothesis generation in microbiome research.
Keywords: bacteria; cancer; contamination; machine learning; microbiome; viruses.
Conflict of interest statement
Colin S. Cooper, Daniel S. Brewer and Abraham Gihawi are co-inventors on a patent application (UK Patent Application No. 2200682.9) from the University of East Anglia/UEA Enterprises Limited regarding the application of biomarker bacterial genera in prostate cancer.
Figures
Comment on
-
Microbiome analyses of blood and tissues suggest cancer diagnostic approach.Nature. 2020 Mar;579(7800):567-574. doi: 10.1038/s41586-020-2095-1. Epub 2020 Mar 11. Nature. 2020. Retraction in: Nature. 2024 Jul;631(8021):694. doi: 10.1038/s41586-024-07656-x. PMID: 32214244 Free PMC article. Retracted.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
